CYP1A1 Ile462Val polymorphism and susceptibility to lung cancer: A meta-analysis based on 32 studies

European Journal of Cancer Prevention

Volumn 20, Issue 6, 2011, Pages 445-452

  Wang, Jing Jun ^a   Zheng, Yuan ^a   Sun, Liang ^a   Wang, Li ^a   Yu, Peng Bo ^a   Li, Hong Lei ^a   Tian, Xiao Ping ^a   Dong, Jian Hua ^a   Zhang, Lei ^a   Xu, Jing ^a   Shi, Wei ^a   Ma, Tao Yan ^a  

^a Department of Center for Disease Control and Prevention of Shaanxi Province ^*  (China)

Author keywords

CYP1A1 polymorphism; lung cancer; meta analysis

Indexed keywords

CYTOCHROME P450 1A1; CYP1A1 PROTEIN, HUMAN; ISOLEUCINE; VALINE;

AFRICAN AMERICAN; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; LUNG CANCER; MEDLINE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; REVIEW; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYMOLOGY; ETHNOLOGY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; META ANALYSIS;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ISOLEUCINE; LUNG NEOPLASMS; POLYMORPHISM, GENETIC; VALINE;

EID: 80053642980     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328345f937     Document Type: Review

References (46)

1. Alexandrie AK, Sundberg MI, Seidegard J, Tornling G, Rannug A (1994). Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis 15:1785-1790.
2. Androutsopoulos VP, Tsatsakis AM, Spandidos DA (2009). Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. BMC Cancer 9:187.
3. Bouchardy C, Wikman H, Benhamou S, Arihirvonen Dayer P, Husgafvel-Pursiainen K (1997). CYP1A1 genetic polymorphisms, tobacco smoking and lung cancer risk in a French Caucasian population. Biomarkers 2:131-134. (Pubitemid 127699894)
4. Cantlay AM, Lamb D, Gillooly M, Norrman J, Morrison D, Smith CA, et al. (1995). Association between the CYP1A1 gene polymorphism and susceptibility to emphysema and lung cancer. Clin Mol Pathol 48:M210-M214.
5. Chen S, Xue K, Xu L, Ma G, Wu J (2001). Polymorphisms of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung carcinoma in Chinese population. Mutat Res 458:41-47. (Pubitemid 34246235)
6. Cote ML, Chen W, Smith DW, Benhamou S, Bouchardy C, Butkiewicz D, et al. (2009a). Meta-and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC review. Am J Epidemiol 169:802-814.
7. Cote ML,Yoo W,Wenzlaff AS, Prysak GM, Santer SK, Claeys GB, et al. (2009b). Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis 30:626-635.
8. Crofts F, Cosma GN, Currie D, Taioli E, Toniolo P, Garte SJ (1993). A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis 14: 1729-1731. (Pubitemid 23290880)
9. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials 7:177-188. (Pubitemid 17189972)
10. Dolzan V, Rudolf Z, Breskvar K (2000). Genetic polymorphism of xenobiotic metabolising enzymes in Slovenian lung cancer patients. Pflugers Arch 439:R29-R30.
11. Drakoulis N, Cascorbi I, Brockmoller J, Gross CR, Roots I (1994). Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3-flanking region. Clin Investig 72:240-248. (Pubitemid 24103195)
12. Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634. (Pubitemid 27387172)
13. Gallegos-Arreola MP, Figuera-Villanueva LE, Troyo-Sanroman R, Morgan-Villela G, Puebla-Perez AM, Flores-Marquez MR, et al. (2008). CYP1A1 *2B and *4 polymorphisms are associated with lung cancer susceptibility in Mexican patients. Int J Biol Markers 23:24-30. (Pubitemid 351715541)
14. Hayashi S, Watanabe J, Kawajiri K (1992). High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jpn J Cancer Res 83:866-870.
15. Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558. (Pubitemid 34746062)
16. Houlston RS (2000). CYP1A1 polymorphisms and lung cancer risk: a meta-analysis. Pharmacogenetics 10:105-114. (Pubitemid 30193072)
17. Ishibe N, Wiencke JK, Zuo ZF, McMillan A, Spitz M, Kelsey KT (1997). Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican-and African-Americans. Cancer Epidemiol Biomarkers Prev 6:1075-1080. (Pubitemid 28007420)
18. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. (2008). Cancer statistics, 2008. CA Cancer J Clin 58:71-96. (Pubitemid 351521864)
19. Kihara M, Noda K (1995). Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 16:2331-2336.
20. Kumar M, Agarwal SK, Goel SK (2009). Lung cancer risk in north Indian population: role of genetic polymorphisms and smoking. Mol Cell Biochem 322:73-79.
21. Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR, et al. (1998). Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 58:4858-4863. (Pubitemid 28503682)
22. Lee KM, Kang D, Clapper ML, Ingelman-Sundberg M, Ono-Kihara M, Kiyohara C, et al. (2008). CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations. Cancer Epidemiol Biomarkers Prev 17:1120-1126.
23. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748.
24. McManus ME, Burgess WM, Veronese ME, Huggett A, Quattrochi LC, Tukey RH (1990). Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cyto-chromes P-450. Cancer Res 50:3367-3376. (Pubitemid 20190145)
25. Nebert DW (1991). Role of genetics and drug metabolism in human cancer risk. Mutat Res 247:267-281.
26. Nebert DW, Dalton TP (2006). The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 6:947-960. (Pubitemid 44862679)
27. Ng DP, Tan KW, Zhao B, Seow A (2005). CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation. Cancer Causes Control 16:399-405. (Pubitemid 40897832)
28. Ozturk O, Isbir T, Yaylim I, Kocaturk CI, Gurses A (2003). GST M1 and CYP1A1 gene polymorphism and daily fruit consumption in Turkish patients with non-small cell lung carcinomas. In vivo 17:625-632. (Pubitemid 38165465)
29. Persson I, Johansson I, Lou YC, Yue QY, Duan LS, Bertilsson L, et al. (1999). Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients. Int J Cancer 81:325-329. (Pubitemid 29165187)
30. Pisani P, Srivatanakul P, Randerson-Moor J, Vipasrinimit S, Lalitwongsa S, Unpunyo P, et al. (2006). GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand. Cancer Epidemiol Biomarkers Prev 15:667-674.
31. Quinones L, Lucas D, Godoy J, Caceres D, Berthou F, Varela N, et al. (2001). CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett 174:35-44. (Pubitemid 33001306)
32. Ratnasinghe D, Tangrea JA, Stewart C, Bhat NK, Virtamo J, Albanes D, et al. (2001). Influence of antioxidants and the CYP1A1 isoleucine to valine polymorphism on the smoking-lung cancer association. Anticancer Res 21:1295-1299. (Pubitemid 32494136)
33. Rohlfs RV, Weir BS (2008). Distributions of Hardy-Weinberg equilibrium test statistics. Genetics 180:1609-1616.
34. Song N, Tan W, Xing D, Lin D (2001). CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis 22:11-16. (Pubitemid 32098138)
35. Spiro SG, Tanner NT, Silvestri GA, Janes SM, Lim E, Vansteenkiste JF, et al. (2010). Lung cancer: progress in diagnosis, staging and therapy. Respirology 15:44-50.
36. Sugimura H, Hamada GS, Suzuki I, Iwase T, Kiyokawa E, Kino I, et al. (1995). CYP1A1 and CYP2E1 polymorphism and lung cancer, case-control study in Rio de Janeiro, Brazil. Pharmacogenetics 5:S145-S148.
37. Sunaga N, Kohno T, Yanagitani N, Sugimura H, Kunitoh H, Tamura T, et al. (2002). Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarci-noma susceptibility. Cancer Epidemiol Biomarkers Prev 11:730-738. (Pubitemid 34851907)
38. Taioli E, Ford J, Trachman J, Li Y, Demopoulos R, Garte S (1998). Lung cancer risk and CYP1A1 genotype in African Americans. Carcinogenesis 19:813-817. (Pubitemid 28376772)
39. Tobias A (1999). Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 8:15-17.
40. Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, Schwartz DR, et al. (2005). CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 26:2207-2212. (Pubitemid 41672209)
41. Wrensch MR, Miike R, Sison JD, Kelsey KT, Liu M, McMillan A, et al. (2005). CYP1A1 variants and smoking-related lung cancer in San Francisco Bay area Latinos and African Americans. Int J Cancer 113:141-147. (Pubitemid 39507321)
42. Xue K, Xu L, Chen S, Ma G, Wu J (2001). Polymorphisms of the CYP1A1 and GSTM1 genes and their combined effects on individual susceptibility to lung cancer in a Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18:125-127.
43. Yang XR, Wacholder S, Xu Z, Dean M, Clark V, Gold B, et al. (2004). CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women. Cancer Lett 214:197-204. (Pubitemid 39207981)
44. Yang M, Choi Y, Hwangbo B, Lee JS (2007). Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer 57:135-142. (Pubitemid 47043185)
45. Yoon KA, Kim JH, Gil HJ, Hwang H, Hwangbo B, Lee JS (2008). CYP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women. Lung Cancer 60:40-46. (Pubitemid 351434467)
46. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland LB, et al. (2008). A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis 29:1164-1169. (Pubitemid 351958695)